Trade HURA anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
TuHURA Biosciences, Inc. (HURA) is trading at US$2.14, up 1.90% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$127.45M. Over the past 52 weeks, HURA has traded between US$0.41 and US$3.43. On Syfe you can trade HURA with $0 commission and add it to your watchlist.
| Previous close | US$2.10 |
|---|---|
| Market cap | US$127.45M |
| 52-week range | US$0.41 – US$3.43 |
| Volume | 367.76K |
| Exchange | US |
Add to Watchlist
Set Price Alert
TuHURA Biosciences, Inc.
TuHURA Biosciences, Inc. is a clinical-stage immuno-oncology company, which engages in the development of novel technologies to overcome resistance to cancer immunotherapy. Its lead product candidate, IFx2.0, is an innate immune agonist designed to overcome primary resistance to checkpoint inhibitors. The company was founded by Michael Lawman, Patricia Lawman and James A. Bianco on May 4, 2023 and is headquartered in Tampa, FL.
Year: 2024
TuHURA Biosciences Files New Drug Application for Evaluation of Antibody to Treat Subsets of AML
Jun 15, 12:33 PM · MT Newswires
TuHURA Biosciences, Inc. (HURA) stock is trading at US$2.14, +1.90% from the previous close of US$2.10.
The market cap for TuHURA Biosciences, Inc. (HURA) stock is approximately US$127.45M.
The 52-week high for TuHURA Biosciences, Inc. (HURA) stock is US$3.43.
The 52-week low for TuHURA Biosciences, Inc. (HURA) stock is US$0.41.
TuHURA Biosciences, Inc. (HURA) does not currently pay a dividend.
Stay on top of HURA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
